SCHEMBL322133

SCHEMBL322133

CC1C2CCC(C)(C2)C1(C)O

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cis-3-Hexenol SCHEMBL23610317 0.79
SCHEMBL4174623 0.78 APOBEC3A (0.30)
Ammonia Solution, Strong SCHEMBL5035447 0.76
SCHEMBL6600194 0.73
SCHEMBL9788201 0.72
SCHEMBL7395108 0.72 MAPK1 (0.41) LMNAMAPK1
SCHEMBL2563670 0.67 ALOX15 (0.41) ALOX15
SCHEMBL2160121 0.67 CYP1A2 (0.41)
SCHEMBL4817757 0.67 SIGMAR1 (0.32)
SCHEMBL30148437 0.63 ESR1 (0.33) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2591059-A1 METHOD FOR PRODUCING A COLOR- AND/OR EFFECT-PRODUCING MULTILAYER COATING, IN WHICH THE COLOR-FORMING COATING COMPOUND CONTAINS A SUBSTITUTED CYCLOHEXANOL IN ORDER TO REDUCE THE NUMBER OF PINHOLES BASF Coatings GmbH (DE) 2013-05-15 EP claimed
WO-2012004075-A1 METHOD FOR PRODUCING A COLOR- AND/OR EFFECT-PRODUCING MULTILAYER COATING, IN WHICH THE COLOR-FORMING COATING COMPOUND CONTAINS A SUBSTITUTED CYCLOHEXANOL IN ORDER TO REDUCE THE NUMBER OF PINHOLES BASF COATINGS GMBH (DE) 2012-01-12 WO claimed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
EP-4719331-A1 LIGHTENING COMPOSITIONS AND USE OF COMPOUNDS AS DEPIGMENTING AGENTS ChemoSensoryX Biosciences SA (BE) 2026-04-08 EP disclosed
US-20250345252-A1 COMPOSITE MICROCAPSULES FIRMENICH & CIE (CH) 2025-11-13 US disclosed
US-12383477-B2 Composite microcapsules FIRMENICH SA (CH) 2025-08-12 US disclosed
US-12290591-B2 Fragrance compositions FIRMENICH SA (CH) 2025-05-06 US disclosed
CN-119584860-A Comprising biodegradable microcapsule composition 奇华顿股份有限公司 2025-03-07 CN disclosed
WO-2024246279-A1 LIGHTENING COMPOSITIONS AND USE OF COMPOUNDS AS DEPIGMENTING AGENTS CHEMCOM S.A. (BE) 2024-12-05 WO disclosed
US-12016963-B2 Freshening compositions with alkoxylated phenols THE PROCTER & GAMBLE COMPANY (US) 2024-06-25 US disclosed
WO-2024115441-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-06-06 WO disclosed
WO-2018029161-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2018-02-15 WO disclosed
CN-105294402-B Method for extracting high-purity natural fenchyl alcohol from fenchyl alcohol-containing by-product of turpentine 广西壮族自治区林业科学研究院 2017-03-22 CN disclosed
WO-2017001672-A1 MICROCAPSULES GIVAUDAN SA (CH) 2017-01-05 WO disclosed
WO-2016207179-A1 IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2016-12-29 WO disclosed
WO-2016207180-A1 IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2016-12-29 WO disclosed
US-20130331342-A1 SYSTEMS AND METHODS FOR IDENTIFYING COSMETIC AGENTS FOR HAIR/SCALP CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2013-12-12 US disclosed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO disclosed
EP-1835902-A2 SPIRO[BORNYL-2,4'-(1,3-DIOXANES)] AND THEIR USES AS FRAGRANCE INGREDIENTS Givaudan SA (CH) 2007-09-26 EP disclosed
WO-2006072189-A2 SPIRO [BORNYL - 2 , 4' - ( 1 , 3 -DIOXANES) ] AND THEIR USES AS FRAGRANCE INGREDIENTS GIVAUDAN SA (CH) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345252-A1 COMPOSITE MICROCAPSULES PLIN5, LIPA, PHOSPHO1 ALDH1A1 3819/4885LMNA 539/4885THRB 4373/4885
US-12383477-B2 Composite microcapsules PLIN5, LIPA, PHOSPHO1 ALDH1A1 3819/4885LMNA 539/4885THRB 4373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.